文献速递肝病消化道出血

对静脉曲张出血患者风险分层标准的多中心外部验证

Multicenter External Validation of Risk Stratification Criteria for Patients With Variceal Bleeding.
PubMed 文献 · Clin Gastroenterol Hepatol · 2017-05-10

该观察性研究纳入2006至2014年加拿大和欧洲915例接受标准治疗的肝硬化急性静脉曲张出血患者,随访至42天。早期TIPS标准、MELD19标准和ChildC-C1标准均可区分高死亡风险患者,Child-Pugh B级伴或不伴活动性出血死亡率相似(11.7%),Child-Pugh C级和/或MELD≥19分应视为高死亡风险。

要点

  • Child-Pugh B级肝硬化急性静脉曲张出血患者接受标准治疗,无论内镜下是否有活动性出血,6周死亡率均为11.7%。
  • Child-Pugh C级和/或MELD评分≥19分的患者6周死亡率高(22%-46%),应视为高死亡风险。
  • 早期TIPS标准、MELD19标准和ChildC-C1标准均可区分高死亡风险与低死亡风险患者。

核心结论

  • Child-Pugh B级肝硬化急性静脉曲张出血患者接受标准治疗,无论有无活动性出血,死亡率较Child-Pugh C级低3倍,可能不需要TIPS。
  • Child-Pugh C级和/或MELD评分≥19分的患者应视为高死亡风险。
  • 这些发现可能有助于完善早期TIPS的标准。

研究设计与样本

  • 观察性研究,纳入2006至2014年间加拿大和欧洲915例接受标准治疗(药物、抗生素、内镜下套扎,TIPS作为挽救治疗)的肝硬化急性静脉曲张出血患者。
  • 所有患者随访至首次急性静脉曲张出血后第42天(第6周)或死亡。
  • Child-Pugh和MELD评分在入院时计算。

主要发现

  • 915例急性静脉曲张出血患者中,18%在6周内死亡。
  • 符合早期TIPS标准的523例患者中,17%在6周内死亡。
  • 早期TIPS标准:高危患者28.3%死亡 vs 低危患者7.0%死亡;MELD19标准:高危患者46.0%死亡 vs 低危患者8.1%死亡;ChildC-C1标准:高危患者51.9%死亡 vs 低危患者10.9%死亡。
  • Child-Pugh B级患者死亡率11.7%,显著低于Child-Pugh C级的35.6%(P ≤ .001)。
  • Child-Pugh B级肝硬化伴或不伴活动性出血患者死亡率相似(11.7%)。

关键数值与推荐

  • 早期TIPS标准:Child-Pugh B级伴内镜下活动性出血或Child-Pugh C级。
  • MELD19标准:MELD评分≥19分。
  • ChildC-C1标准:Child-Pugh C级伴血浆肌酐≥1 mg/dL。

临床怎么用

  • Child-Pugh B级肝硬化急性静脉曲张出血患者接受标准治疗,无论有无活动性出血,可能不需要TIPS。
  • Child-Pugh C级和/或MELD评分≥19分的患者应视为高死亡风险。
  • 上述发现可能有助于完善早期TIPS的标准。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Early placement of a transjugular intrahepatic portosystemic shunts (TIPS) is considered the treatment of choice for patients with acute variceal bleeding (AVB) and cirrhosis who have a high risk of death (Child-Pugh class B with active bleeding at endoscopy or Child-Pugh class C). It has been proposed that patients of Child-Pugh class B, even with active bleeding, should not be considered high risk. Alternative criteria have been proposed for identification of high-risk patients, such as Child-Pugh class C with plasma level of creatinine of 1 mg/dL or more (ChildC-C1) and a model for end-stage liver disease (MELD) score of 19 or more. We analyzed outcomes of a large cohort of patients with AVB who received the standard of care at different centers to validate these systems of risk stratification. METHODS: We performed an observational study of 915 patients with liver cirrhosis and AVB who received standard treatment (drugs, antibiotics, and endoscopic ligation, with TIPS as the rescue treatment), over different time periods between 2006 and 2014 in Canada and Europe. All patients were followed until day 42 (week 6) after index AVB or death. Child-Pugh and MELD scores were calculated at time of hospital admission. The primary outcome was mortality 6 weeks after index AVB among patients who met the early TIPS criteria (Child-Pugh class B with active bleeding at endoscopy or Child-Pugh class C), MELD19 criteria (patients with MELD scores of 19 or more), and ChildC-C1 criteria. RESULTS: Among 915 patients with AVB, 18% died within 6 weeks. Among the 523 patients who met the early TIPS criteria, 17% died within 6 weeks. All 3 rules discriminated patients at high risk of death from those with low risk: 28.3% of the patients classified as high risk by the early TIPS criteria died whereas only 7.0% of patients classified as low risk died; 46.0% of patients classified as high risk by the MELD19 criteria died vs 8.1% of patients classified as low risk; 51.9% of patients classified as high risk by the ChildC-C1 criteria died compared with 10.9% of patients classified as low risk. Mortality was significantly lower among patients with Child-Pugh class B (11.7%) than with Child-Pugh class C (35.6%) (P ≤ .001). Mortality was similar between patients with Child-Pugh class B cirrhosis with or without active bleeding (11.7%). Patients with Child-Pugh class A cirrhosis or MELD scores of 11 or less had low mortality (2%-4%), patients with Child-Pugh class B cirrhosis or MELD scores of 12 to 18 had intermediate mortality (10%-12%), and patients with Child-Pugh class C cirrhosis or MELD scores of 19 or more had high mortality (22%-46%). CONCLUSIONS: Patients with Child-Pugh class B cirrhosis and AVB who receive standard therapy, regardless of the presence of active bleeding, have 3-fold lower mortality than patients with Child-Pugh C cirrhosis and might not need TIPS. Patients with Child-Pugh class C and/or MELD scores of 19 or more should be considered at high risk of death. These findings might help refine criteria for early TIPS.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Conejo I, Guardascione MA, Tandon P, et al. Multicenter External Validation of Risk Stratification Criteria for Patients With Variceal Bleeding. Clin Gastroenterol Hepatol. 2017. PMID: 28501536. doi:10.1016/j.cgh.2017.04.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。